242
Participants
Start Date
March 31, 2009
Primary Completion Date
October 31, 2013
Study Completion Date
March 31, 2014
ranibizumab
Two ranibizumab subconjunctival injections (0.5 mg ∕ 0.05 mL). The first injection at the end of the surgery (intraoperative) and the second two weeks post-operatively.
standard care
standard post-operative care after trabeculectomy with mitomycin C
Maisonneuve-Rosemont Hospital, Montreal
Collaborators (1)
Novartis
INDUSTRY
Maisonneuve-Rosemont Hospital
OTHER